Title : Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.

Pub. Date : 2015 Jul

PMID : 25701378






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. Celecoxib AKT serine/threonine kinase 1 Homo sapiens
2 We further show that combined treatment with celecoxib and rapamycin results in an additive inhibitory effect on the growth of gastric cancer cells through suppression of rapamycin-induced Akt activation. Celecoxib AKT serine/threonine kinase 1 Homo sapiens
3 Knockdown of Cbl-b significantly attenuated celecoxib-mediated inhibition of Akt phosphorylation and impaired the additive anticancer effect of celecoxib and rapamycin. Celecoxib AKT serine/threonine kinase 1 Homo sapiens
4 Our results suggest that celecoxib-mediated upregulation of Cbl-b is responsible, at least in part, for the additive antitumor effect of celecoxib and rapamycin via inhibition of rapamycin-induced Akt activation. Celecoxib AKT serine/threonine kinase 1 Homo sapiens
5 Our results suggest that celecoxib-mediated upregulation of Cbl-b is responsible, at least in part, for the additive antitumor effect of celecoxib and rapamycin via inhibition of rapamycin-induced Akt activation. Celecoxib AKT serine/threonine kinase 1 Homo sapiens